Earlier this month, Neuralink discovered that ultrathin electrodes implanted in the cerebral cortex of Noland Arbo’s first patient had become dislodged. It was reported that the company was aware of this potential problem, as similar problems were experienced in animal testing.

To solve this problem, Neuralink plans to insert ultra-thin electrodes deeper into the cerebral cortex to increase stability.

When is the second patient operated on?

The operation is planned for June, which will be the next phase of Neuralink’s ambitious plan to go public. 10 such operations during the year. The company’s patient registry currently includes more than 1,000 paralyzed people eagerly awaiting their turn for a potentially life-changing procedure.

Neuralink plans to expand its activities internationally in the future. The company plans to apply to regulatory authorities in Canada and Great Britain in the coming months for permission to perform brain implant operations in those countries.

Neuralink’s success is a significant step forward in the field of neuroengineering. They offer hope for progress in the treatment of serious neurological diseases. As the company continues to improve its technology and expand its scope, the potential benefits for patients with stroke and other neurological disorders could be transformative.